関連する実験動画
Updated: Mar 31, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
肥満と闘うための無益な方法?
Shannon M Reilly1, Alan R Saltiel1
1Department of Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Cell
|October 27, 2015
まとめ
研究者らは脂肪細胞の 熱生成を促進する 新しい分子経路を発見しました この発見は 肥満の流行を食い止めるための 新しい目標として エネルギー消費を増やすことで 減量を促進します
科学分野:
- 代謝に関する研究
- 肥満に関する研究
- 細胞生物学
背景:
- 肥満の流行は エネルギーバランスの仕組みを理解する必要があります
- エネルギー消費は基礎代謝,身体活動,適応性発熱によって影響を受ける.
- 熱生成をターゲットにすることで 体重管理の戦略が生まれます
研究 の 目的:
- 熱生成を制御する新しい分子経路を特定する.
- 肥満の新たな治療法を探求するためです
主な方法:
- 脂肪細胞における熱生成の分子機構を研究した.
- 細胞生物学や分子生物学を使った
- 以前は未知の経路を 特定することに焦点を当てました
主要な成果:
- 熱生成のための新しい分子経路を記述した.
- 脂肪細胞のエネルギー消費を制御する 新しいメカニズムが示されました
- 熱生成を制御する 標的を特定した
結論:
- この研究は 熱生成に不可欠な 新しい分子経路を示しています
- この発見は 肥満と闘うための戦略を 開発する道を開きます
- この経路をターゲットにすると エネルギー消費が増加し 体重減少が促進されます
関連する概念動画
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
283
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
283
Atherosclerosis III: Management
582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Binge Eating Disorders
757
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
757

